Rapivab
Product Images NDC 72769-181

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Rapivab (NDC 72769-181). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocryst Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rapivab 01

Chemical structure of the active ingredient in Rapivab, illustrating its molecular composition including functional groups and hydration state as a trihydrate (3 H2O). The diagram shows atoms and bonds consistent with a complex organic molecule.*

FDA Label Image

Principal Display Panel (200 mg/20 mL Vial Carton)

Packaging label for Rapivab peramivir injection, 200 mg/20 mL per vial (10 mg/mL), manufactured by BioCryst Pharmaceuticals, Inc. The carton is labeled for intravenous infusion only, with dilution before use. It states the carton contains 3 vials and includes a barcode and storage information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.